UPDATE: Roth Capital Downgrades Humanigen (HGEN) to Neutral Jul 13, 2022 09:02AM
Humanigen (HGEN) PT Lowered to $19 at Roth Capital, Following Clinical Business Update Sep 9, 2021 11:26AM
Humanigen (HGEN) PT Raised to $37 at Roth Capital May 5, 2021 12:55PM
Humanigen Inc. (HGEN) Prices 5M Share Common Offering at $18.50/Sh Mar 31, 2021 06:04AM
Humanigen Announces Pricing of Public Offering of Five Million Shares of Common Stock Mar 30, 2021 08:08PM


Mar 29, 2021 04:11PM Humanigen Inc. (HGEN) Announces Proposed Public Offering of 5M Shares of Common Stock
Mar 29, 2021 04:11PM Humanigen Announces Proposed Public Offering of Five Million Shares of Common Stock
Jan 11, 2021 06:24AM Humanigen (HGEN) Announces Partnership to Commercialize Nasal Spray that Fights COVID Cytokine Storm, Expects EUA - Roth Capital
Oct 27, 2020 04:01PM Humanigen to Present at Upcoming Investor Conferences
Sep 22, 2020 02:25PM Humanigen Announces Closing of Public Offering of Common Stock
Sep 22, 2020 02:00PM Humanigen Announces Closing of Public Offering of Common Stock
Sep 18, 2020 05:54AM Humanigen Inc. (HGEN) Prices 8M Share Common Offering at $8.50/Sh
Sep 17, 2020 09:10PM Humanigen Announces Pricing of Public Offering of Common Stock and Commencement of Trading on Nasdaq Under the Symbol “HGEN”
Sep 17, 2020 08:30PM Humanigen Announces Pricing of Public Offering of Common Stock and Commencement of Trading on Nasdaq Under the Symbol “HGEN”